November 13, 2025 ~ Lucy Ann Lance is joined by Dr. Gustav Lo, MD Chief Medical Officer and Founder, RegenCen. The FDA is removing the warning labels on hormone replacement therapy, a major shift after two decades of confusion and fear following the release of a flawed study linking HRT to breast cancer.